[144] Credit Acceptance Corp SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Credit Acceptance Corp (CACC) reports a proposed sale of 10,000 shares of common stock through UBS Financial Services with an aggregate market value of $5,150,000. The filing shows those shares were acquired on 10/01/2008 as a GRAT remainder. The seller lists approximately 11,237,661 shares outstanding for the class and indicates an approximate sale date of 09/09/2025 on the NASDAQ. The filing also discloses a recent sale within the past three months by a related trust: 20,000 common shares sold on 07/02/2025 for $15,874,245 gross proceeds. The notice includes the standard representation that the seller has no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider intends to sell 10,000 shares (filed under Rule 144); transaction appears routine and disclosure-compliant.

The Form 144 documents a proposed sale of 10,000 common shares via UBS, acquired as a GRAT remainder in 2008. The filing provides the aggregate market value and an approximate sale date, and discloses a related trust sale of 20,000 shares earlier in July 2025. From an informational standpoint, the filing is complete for Rule 144 purposes: it specifies acquisition details, broker, planned sale date, and recent related transactions. There is no operational or financial performance data in this filing; its primary relevance is to SEC-compliant insider liquidity rather than company fundamentals.

Corporate Governance Expert

TL;DR: Filing is a standard Rule 144 liquidity notice; it confirms insider disposal activity but gives no new governance concerns.

The form includes the required representation that the filer lacks undisclosed material adverse information and notes the securities were acquired via a GRAT remainder. It also lists the broker and recent sales by an associated trust. This satisfies disclosure obligations under Rule 144; there is no indication in the filing of unusual restrictions, related-party irregularities, or regulatory exceptions. Material governance implications are not evident from the information provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	10000	5150000	11237661	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2008	GRAT Remainder	Founders Shares			10000	10/01/2008	GRAT Remainder

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jill Foss Watson Living Trust c/o UBS Financial Services 2000 Ave of the Stars Los Angeles CA 90067	Common	07/02/2025	20000	15874245

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CACC disclose about the proposed sale?

The Form 144 discloses a proposed sale of 10,000 common shares via UBS with an aggregate market value of $5,150,000 and an approximate sale date of 09/09/2025.

When and how were the shares being sold on Form 144 acquired?

The shares were acquired on 10/01/2008 as a GRAT remainder, and the table lists the acquisition date and nature of acquisition.

Does the filing show any recent related sales by the same person or related trust?

Yes. The filing reports that the Jill Foss Watson Living Trust sold 20,000 common shares on 07/02/2025 for gross proceeds of $15,874,245.

Which broker is handling the proposed sale in the CACC Form 144?

The broker listed is UBS Financial Services Inc, located at 1000 Harbor Blvd, Weehawken, NJ.

Does the Form 144 assert any undisclosed material information about CACC?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.